Eudaimonia Advisors’s Johnson & Johnson JNJ Stock Holding History

Eudaimonia Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$804K	Sell	5,082 -1,559	-23%	-$248K	0.43%	70
2023 Q4	$1.04M	Sell	6,641 -56	-0.8%	-$8.59K	0.67%	42
2023 Q3	$1.04M	Sell	6,697 -636	-9%	-$105K	0.73%	39
2023 Q2	$1.21M	Sell	7,333 -486	-6%	-$78.4K	0.81%	34
2023 Q1	$1.21M	Sell	7,819 -112	-1%	-$18.1K	0.82%	35
2022 Q4	$1.4M	Sell	7,931 -39	-0.5%	-$6.73K	0.95%	28
2022 Q3	$1.3M	Buy	7,970 +95	+1%	+$16.1K	0.9%	26
2022 Q2	$1.4M	Buy	7,875 +314	+4%	+$55.9K	0.96%	25
2022 Q1	$1.34M	Buy	7,561 +225	+3%	+$38.3K	0.77%	33
2021 Q4	$1.25M	Buy	+7,336	New	+$1.2M	0.74%	35

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Eudaimonia Advisors's JNJ Position: Q1 2024 in Review

Eudaimonia Advisors reduced its Johnson & Johnson (JNJ) stake by 23% in Q1 2024, selling an estimated $248K and leaving 5,082 shares worth $804K. The position accounts for 0.43% of the portfolio, ranked #70.

Eudaimonia Advisors first reported a position in JNJ in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.4M in Q4 2022. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

Eudaimonia Advisors held 5,082 shares of Johnson & Johnson worth $804K as of Q1 2024.
Eudaimonia Advisors sold 1,559 Johnson & Johnson shares in Q1 2024, an estimated $248K.
Johnson & Johnson made up 0.43% of Eudaimonia Advisors's portfolio in Q1 2024, its #70 holding.
Eudaimonia Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 10 quarters since.
Eudaimonia Advisors's Johnson & Johnson position peaked at $1.4M in Q4 2022.
3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Eudaimonia Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.